MUMBAI, India, May 29 -- Intellectual Property India has published a patent application (202641044283 A) filed by Saveetha Institute Of Medical And Technical Sciences, 162, POOMALLEE HIGH ROAD, A61K VELLAPANCHAVADI, CHENI-600077, TAMIL DU, INDIA Tamil Nadu 6/00, India A61L, on April 7, for 'synergistic bioactive gelatin composite incorporating extracts from moringa & nbsp; oleifera and camellia sinensis exhibiting dental tissue regeneration, antioxidant and anti-inflammatory properties.'
Inventor(s) include Priyatha Prasanth; Arvina Rajasekar; and Deepak Nallaswamy Veeraiyan.
The application for the patent was published on May 29, under issue no. 22/2026.
According to the abstract released by the Intellectual Property India: "The present invention discloses a novel gelatin-based biocomposite developed via controlled aqueous extraction ofMoringa oleifera and Camellia sinensis leaves under mild thermal conditions (50-60 C), producing a phytochemically enriched biomaterial engineered for advanced dental and biomedical applications. The biocomposite comprises gelatin (5-25% w/v) as the primary biodegradable matrix, Moringa oleitera extract (0.5- 1 0% w/w) rich in flavonoids and phenolic compounds, Camellia sinensis extract (0.5-8% w/w) rich in catechins and polyphenols. The invention provides a homogeneous, stable, and processable biocomposite matrix formed by controlled incorporation of the concentrated plant extracts into the gelatin solution, enabling fabrication as films, membranes, scaffolds, coatings, and drug-delivery systems. The resulting biocomposite exhibits superior antioxidant activity ( 75% DPPH scavenging), significant antiinflammatory effect ( 60% reduction in pro-inflammatory cytokines), and excellent cytocompatibility with human gingival fibroblasts (cell viability 85%), supporting accelerated tissue repair. The synergistic interaction between the gelatin matrix and plantderived polyphenols enables controlled bioactive release over 7-14 days, enhancing therapeutic efficacy and sustained local action. The material is particularly suited for periodontal therapy, wound healing, implant surface coatings, pulp therapy, socket preservation, guided tissue regeneration, and post-surgical inflammation control. The invention overcomes major limitations of existing dental biomaterials by integrating natural therapeutics into a biodegradable, biocompatible platform that effectively regulates oxidative stress and inflammation in oral tissues. The invention offers a safe, cost-effective, scalable, and eco-friendly alternative to conventional synthetic dental biomaterials, advancing the standard of care in regenerative dentistry."
Disclaimer: Curated by HT Syndication.
